These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1061006)

  • 1. Acute leukemia in advanced ovarian carcinoma after treatment with alkylating agents.
    Sotrel G; Jafari K; Lash AF; Stepto RC
    Obstet Gynecol; 1976 Jan; 47(1):67S-71S. PubMed ID: 1061006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute leukemia after alkylating-agent therapy of ovarian cancer.
    Reimer RR; Hoover R; Fraumeni JF; Young RC
    N Engl J Med; 1977 Jul; 297(4):177-81. PubMed ID: 406560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.
    Greene MH; Boice JD; Greer BE; Blessing JA; Dembo AJ
    N Engl J Med; 1982 Dec; 307(23):1416-21. PubMed ID: 6752720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia and other myelopathic disorders following treatment with alkylating agents.
    Bennett JM; Moloney WC; Greene MH; Boice JD
    Hematol Pathol; 1987; 1(2):99-104. PubMed ID: 3504435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A stage IIIc ovarian cancer case of pathological CR after combination treatment with carboplatin and cisplatin].
    Onishi Y; Maruyama H; Kume K; Hatae M
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2053-6. PubMed ID: 8085858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute leukemia secondary to the treatment of multiple sclerosis with chlorambucil].
    Aymard JP; Witz F; Conroy T; Lederlin P; Humbert JC; Barroche G; Streiff F
    Rev Neurol (Paris); 1985; 141(2):152-4. PubMed ID: 3858929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer.
    Lerner HJ
    Cancer Treat Rep; 1978 Aug; 62(8):1135-8. PubMed ID: 278642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia following non-Hodgkin's lymphoma: danger of prolonged use of chlorambucil as maintenance therapy.
    Dumont J; Thiery JP; Mazabraud A; Natali JC; Trapet P; Vilcoq JR
    Nouv Rev Fr Hematol (1978); 1980; 22(4):391-404. PubMed ID: 6942388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A patient with ovarian cancer metastasis cured (?) by cytostatic agents and died from acute myeloid leukemia].
    Sypkens Smit CG; Meyler L
    Ned Tijdschr Geneeskd; 1970 Sep; 114(39):1620-3. PubMed ID: 4990178
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
    Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pyoderma gangrenosum, ovarian carcinoma treated with Melphalan and acute myelomonocytic leukaemia: report of one case and literature review (author's transl)].
    Ortonne JP; Thivolet J; Chouvet B; Coiffet J
    Ann Dermatol Venereol; 1979 Mar; 106(3):251-6. PubMed ID: 290349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute erythroleukemia complicating prolonged chemotherapy for ovarian carcinoma.
    Khandekar JD; Kurtides ES; Stalzer RC
    Arch Intern Med; 1977 Mar; 137(3):355-6. PubMed ID: 402895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia after treatment of ovarian cancer with alkylating agents.
    Parker LM
    N Engl J Med; 1983 Jun; 308(23):1422. PubMed ID: 6843637
    [No Abstract]   [Full Text] [Related]  

  • 17. [Induced malignant hemopathies. 6 new cases with 1 patient surviving 45 months].
    Clément F
    Schweiz Med Wochenschr; 1979 Apr; 109(15):544-51. PubMed ID: 286415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute leukaemia after alkylating-agent therapy of ovarian cancer.
    Bell DR; Woods RL; Levi JA
    Med J Aust; 1982 Sep; 2(5):243-4. PubMed ID: 7132879
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term survival in a case of stage IV carcinoma of the ovary treated with a single chemotherapeutic agent.
    Akbiyik N; Solisio E; Alexander L
    J Natl Med Assoc; 1979 Aug; 71(8):757-9. PubMed ID: 226723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukaemia after treatment with cytostatic agents.
    Smit CG; Meyler L
    Lancet; 1970 Sep; 2(7674):671-2. PubMed ID: 4195813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.